{
  "id": "6446caac57b1c7a315000074",
  "type": "list",
  "question": "Which are the types of Charcot-Marie-Tooth Disease (CMT)?",
  "ideal_answer": "CMT1, or hypertrophic form in which mutations or a duplication were found on chromosome 17 is the most frequent (CMT1A), CMT2 is the neuronal form, CMT3 is termed the Dejerine-Sottas disease, CMT4 recessive forms, CMT5 a form with associated pyramidal features, and CMTX.",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/32504000",
    "http://www.ncbi.nlm.nih.gov/pubmed/20163430",
    "http://www.ncbi.nlm.nih.gov/pubmed/34540429",
    "http://www.ncbi.nlm.nih.gov/pubmed/24198383",
    "http://www.ncbi.nlm.nih.gov/pubmed/9686263",
    "http://www.ncbi.nlm.nih.gov/pubmed/16775364",
    "http://www.ncbi.nlm.nih.gov/pubmed/28364294",
    "http://www.ncbi.nlm.nih.gov/pubmed/12185164",
    "http://www.ncbi.nlm.nih.gov/pubmed/8128981",
    "http://www.ncbi.nlm.nih.gov/pubmed/1549221",
    "http://www.ncbi.nlm.nih.gov/pubmed/8810804",
    "http://www.ncbi.nlm.nih.gov/pubmed/24846915",
    "http://www.ncbi.nlm.nih.gov/pubmed/17437620",
    "http://www.ncbi.nlm.nih.gov/pubmed/12901697",
    "http://www.ncbi.nlm.nih.gov/pubmed/15549395"
  ],
  "snippets": [
    {
      "text": "There are four types: CMT1, CMT2, CMT3 and CMT4, depending upon the involvement of specific gene deficit, inheritance pattern, age of onset and whether the primary defect results in an abnormality of the myelin or axon of the nerve.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/34540429",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Clinically, CMT can be divided into two main types: a demyelinating type (CMT1, CMT3, CMT4 and CMTX1) and an axonal type (CMT2)",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/24846915",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": " CMT1, or hypertrophic form in which mutations or a duplication were found on chromosome 17 is the most frequent (CMT1A), CMT2 is the neuronal form, CMT3 is termed the Dejerine-Sottas disease, CMT4 recessive forms, CMT5 a form with associated pyramidal features, and CMTX. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/9686263",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Charcot-Marie-Tooth (CMT) is a group of inherited diseases clinically and genetically heterogenous, characterised by length dependent degeneration of axons of the peripheral nervous system. A missense mutation (p.R158H) in the pyruvate dehydrogenase kinase 3 gene (PDK3) has been identified as the genetic cause for an X-linked form of CMT (CMTX6) in two unrelated families. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/32504000",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The subdivision into demyelinating CMT1 and axonal CMT2 types was a milestone and is still valid for the majority of patients.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/16775364",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Intermediate conduction velocities are often found in males with X-linked CMT (CMTX), and different intermediate CMT types have been identified",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/16775364",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The association of neuropathy and optic atrophy (also known as CMT type 6) has been described with autosomaldominant, recessive and X-linked modes of inheritance.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/24198383",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Mutations in Mitofusin 2 have been found to cause dominant forms of CMT6.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/24198383",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Mutations of the gene encoding mitofusin 2 (MFN2) have recently been identified as the cause of approximately one-third of dominantly inherited cases of the axonal degenerative forms of Charcot-Marie-Tooth disease (CMT type 2A) and of rarer variants.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/20163430",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The latter include a severe, early-onset axonal neuropathy, which may occur in autosomal dominant or recessive forms, as well as some instances associated with pyramidal tract involvement (CMT type 5),",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/20163430",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "with optic atrophy (CMT type 6),",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/20163430",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Two principal forms of Charcot-Marie-Tooth (CMT) disease have been distinguished: CMT 1, corresponding to a demyelinating type, and CMT 2, corresponding to an axonal type.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/12901697",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Charcot-Marie-Tooth disease (CMT), the most common inherited peripheral neuropathy, is a progressive sensorimotor neuropathy divided into types 1 and 2 based upon electrophysiologic and neuropathologic differences.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/1549221",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Charcot-Marie-Tooth disease type 1A (CMT1A) is the most common form, exhibiting autosomal dominant inheritance and linkage to chromosome 17p11.2p12.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/8128981",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Recent work has identified the gene products corresponding to CMT1A, CMT1B and CMTX as peripheral myelin protein-22(PMP22), Po and connexin 32, respectively.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/8810804",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "A systematic computer-based literature search was conducted on PubMed, using the following MeSH: (1) intermediate Charcot-Marie-Tooth; (2) X-linked intermediate Charcot-Marie-Tooth; and (3) X-linked Charcot-Marie-Tooth and electrophysiology.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/28364294",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Charcot-Marie-Tooth disease (CMT) has been classified into two types, CMT1 and CMT2, demyelinating and axonal forms, respectively.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/15549395",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Two major types can be distinguished based on electrophysiologic phenotypes: CMT type 1 (CMT1) displays uniformly decreased nerve conduction velocity associated with a demyelinating hypertrophic neuropathy, and CMT type 2 (CMT2) displays normal or near-normal nerve conduction velocity associated with a neuronal defect.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/8128981",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Clinically, CMT can be divided into two main types: a demyelinating type (CMT1, CMT3, CMT4 and CMTX1) and an axonal type (CMT2).",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/24846915",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Common clinical manifestations of CMTX, as in other forms of Charcot-Marie-Tooth disease (CMT), are distal muscle wasting and weakness, hyporeflexia, distal sensory disturbance, and foot deformities.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/12185164",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Charcot-Marie-Tooth disease (CMT) has been classified into two types: demyelinating forms (CMT1) and axonal forms (CMT2).",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/17437620",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "y known to affect 1 in 2500 individuals. There are four types: CMT1, CMT2, CMT3 and CMT4, depending upon the involvement of specific gene deficit, inh",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/34540429",
      "beginSection": "abstract",
      "endSection": "abstract"
    }
  ],
  "concepts": [],
  "exact_answer": "CMT1, CMT1A, CMT2, CMT type 2A, CMT3, CMT4, CMT5, CMT type 5, CMTX, CMTX1, CMTX6, CMT6, CMT type 6"
}